Relation between anxiety and depressive disorders in childhood and adolescence

Depression and Anxiety

Volumn 14, Issue 2, 2001, Pages 67-78

  Axelson, David A ^a   Birmaher, Boris ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adolescence; Anxiety; Child; Depression

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; AFFECTIVE NEUROSIS; ANXIETY; ANXIETY NEUROSIS; BEHAVIOR THERAPY; CHILD; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITION; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG EFFICACY; FAMILY STUDY; GENETICS; HUMAN; NEUROBIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; SEROTONINERGIC SYSTEM; TWINS;

ADOLESCENT; ANXIETY DISORDERS; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PERSONALITY ASSESSMENT; SEROTONIN UPTAKE INHIBITORS;

EID: 0034785994     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/da.1048     Document Type: Review

References (116)

1. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder
2. Replication of empirically derived syndromes as a basis for taxonomy of child/adolescent psychopathology
3. Treatment of social anxiety in adolescents
4. Comorbidity
5. Long-term antidepressant treatment restores clonidine's effect on growth hormone secretion in a genetic animal model of depression
6. Family treatment of childhood anxiety: A controlled trial
7. At risk for anxiety. I. Psychopathology in the offspring of anxious parents
8. Symptoms of anxiety disorders in normal children
9. Attributional style of anxious children: Extensions from cognitive theory and research on adult anxiety
10. Comorbidity and severity of anxiety and depressive disorders in a clinic sample
11. Anxiety disorders in children and adolescents: A review of the past 10 years
12. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders, American Academy of Child and Adolescent Psychiatry
13. Psychiatric comorbidity among referred juveniles with major depression: Fact or artifact?
14. A high risk study of young children of parents with panic disorder and agoraphobia with and without comorbid major depression
15. A 3-year follow-up of children with and without behavioral inhibition
16. Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years
17. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders
18. Growth hormone secretion in children and adolescents at high-risk for major depressive disorder
19. Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder
20. Childhood and adolescent depression: A review of the past 10 years - Part I
21. Fluoxetine for childhood anxiety disorders
22. Treatment of elective mutism with fluoxetine: A double-blind, placebo-controlled study
23. Comorbidity of anxiety and depression in children and adolescents
24. A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive treatments
25. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression
26. Sex differences in depression: A role for preexisting anxiety
27. Behavioral observations at age 3 years predict adult psychiatric disorders: Longitudinal evidence from a birth cohort
28. Social expectancies and self-perceptions in anxiety-disordered children
29. Abnormal regulation of noradrenergic function in panic disorders: Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder
30. Tripartite model of anxiety and depression: Psychometric evidence and taxonomic implications
31. Cognitive-behavioral group treatment of adolescent depression: Prediction of outcome
32. Anxious children and their parents: What do they expect?
33. An epidemiological study of disorders in late childhood and adolescence. I. Age- and gender-specific prevalence
34. A longitudinal look at the relation between depression and anxiety in children and adolescents
35. Relation between symptoms of anxiety and depression in children: A multitrait-multimethod-multigroup assessment
36. The Great Smoky Mountains Study of Youth: Goals, design, methods, and the prevalence of DSM-III-R disorders
37. Psychoneuroendocrinology of depression: Growth hormone
38. Fluoxetine treatment of children with selective mutism: An open trial
39. The assessment of depression and anxiety in hospitalized pediatric patients
40. Genetics and developmental psychopathology. 2. The main effects of genes and environment on behavioral problems in the Virginia Twin Study of Adolescent Behavioral Development
41. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression
42. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents
43. DSM-III-R disorders in New Zealand 18-year-olds
44. Temperament and major depression in 11 to 16 year olds
45. Assessment issues in treatment research of pediatric anxiety disorders: What is working, what is not working, what is missing, and what needs improvement
46. Discriminating depression and anxiety in youth: A role for diagnostic criteria
47. Psychiatric disorders in the relatives of depressed probands. I. Comparison of prepubertal, adolescent and early adult onset cases
48. Child and adult depression: A test of continuities with data from a family study
49. Genetics and developmental psychopathology. 1. Phenotypic assessment in the Virginia Twin Study of Adolescent Behavioral Development
50. Stable behavioral inhibition and its association with anxiety disorder
51. Tripartite structure of positive and negative affect, depression, and anxiety in child and adolescent psychiatric inpatients
52. The physiology and psychology of behavioral inhibition in children
53. Efficacy of paroxetine in the treatment of adolescent major depression: A randomized, controlled trial
54. Temperament and psychopathology amongst siblings of probands with depressive and anxiety disorders
55. Treating anxiety disorders in children: Results of a randomized clinical trial
56. Therapy for youths with anxiety disorders: A second randomized clincal trial
57. Comorbidity of anxiety and depression in youth: Treatment implications
58. Internalizing disorders in childhood
59. A controlled family history study of childhood-onset depressive disorder
60. Depressive disorders in childhood. IV. A longitudinal study of comorbidity with and risk for anxiety disorders
61. Family history in recurrent depression
62. Pharmacologic treatment of child and adolescent depression
63. Anxiety disorders in children and their families
64. A prospective study of childhood anxiety disorders
65. Testing the cognitive content-specificity hypothesis with anxious and depressed youngsters
66. Lifetime comorbidity among anxiety disorders and between anxiety disorders and other mental disorders in adolescents
67. Major depression in community adolescents: Age at onset, episode duration, and time to recurrence
68. Adolescent psychopathology. IV. Specificity of psychosocial risk factors for depression and substance abuse in older adolescents
69. Anxiety and depression in children and adolescents: Negative affectivity and the utility of self-reports
70. Cognitive social skills and social self-appraisal in depressed adolescents
71. DSM-III disorders from age 11 to age 15 years
72. Phenomenology of depression in children and adolescents
73. Role of the serotonin receptor subtype 5-HT1D on basal and stimulated growth hormone secretion
74. Efficacy of interpersonal psychotherapy for depressed adolescents
75. Neuroendocrine control of growth hormone secretion
76. Worry in normal children
77. Increased prevalence and earlier onset of mood disorders among relatives of prepubertal versus adult probands
78. Depression in British and American children and its relation to anxiety and fear
79. Psychopathology in children of parents with recurrent depression
80. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders
81. Ventilatory physiology of children and adolescents with anxiety disorders
82. A controlled family history study of prepubertal major depressive disorder
83. Unipolar depression in adolescence: Clinical outcome in adulthood
84. Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: A review and meta-analysis
85. Psychosocial risks for major depression in late adolescence: A longitudinal community study
86. Comorbidity of unipolar depression. II. Comorbidity with other mental disorders in adolescents and adults
87. Fluvoxamine for the treatment of anxiety disorders in children and adolescents
88. Temperament, personality, and personality disorder
89. Psychoneuroendocrinology of children and adolescents
90. Neuroendocrine response to L-5-hydroxytryptophan challenge in prepubertal major depression: Depressed vs. normal children
91. Clonidine challenge in childhood anxiety disorder
92. Predicting the one year course of adolescent major depression
93. Adolescent social anxiety as an outcome of inhibited temperament in childhood
94. The Virginia Twin Study of Adolescent Behavioral Development. Influences of age, sex, and impairment on rates of disorder
95. Cognitive, behavioral, and family factors in the differentiation of depressive and anxiety disorders during childhood
96. Association between anxiety and depression in children and adolescents with anxiety disorders
97. A twin study of depressive symptoms in childhood
98. Are anxiety symptoms in childhood heritable?
99. Anxiety and depressive symptoms in childhood: A genetic study of comorbidity
100. The genetic architecture of depression and anxiety in youth
101. Self-talk in youth with anxiety disorders: States of mind, content specificity, and treatment outcome
102. Psychopathology in the offspring of anxiety disorders patients
103. Blunted growth hormone response to clonidine in panic disorder patients
104. The prevalence of DSM-III-R diagnose in a national sample of Dutch adolescents
105. Offspring at high and low risk for depression and anxiety: Mechanisms of psychiatric disorder
106. Grandparents, parents, and grandchildren at high risk for depression: A three-generation study
107. Negative affectivity: The disposition to experience aversive emotional states
108. Offspring of depressed parents: 10 Years later
109. Early-onset major depression in parents and their children
110. Depression and anxiety disorders in parents and children: Results from the Yale family study
111. Onset of psychopathology in offspring by developmental phase and parental depression
112. A case-control family history study of depression in adolescents
113. Controlled trial of a brief cognitive-behavioural intervention in adolescent patients with deressive disorders